BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19298847)

  • 41. Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus.
    Vullhorst D; Neddens J; Karavanova I; Tricoire L; Petralia RS; McBain CJ; Buonanno A
    J Neurosci; 2009 Sep; 29(39):12255-64. PubMed ID: 19793984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.
    Dickerson JW; Hemmerle AM; Numan S; Lundgren KH; Seroogy KB
    Neuroscience; 2009 Sep; 163(1):482-9. PubMed ID: 19505538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1).
    Iwakura Y; Zheng Y; Sibilia M; Abe Y; Piao YS; Yokomaku D; Wang R; Ishizuka Y; Takei N; Nawa H
    J Neurochem; 2011 Jul; 118(1):45-56. PubMed ID: 21517852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
    J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans.
    Zheng Y; Watakabe A; Takada M; Kakita A; Namba H; Takahashi H; Yamamori T; Nawa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):701-6. PubMed ID: 19336245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat.
    Steiner H; Blum M; Kitai ST; Fedi P
    Exp Neurol; 1999 Oct; 159(2):494-503. PubMed ID: 10506520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta.
    Thuret S; Alavian KN; Gassmann M; Lloyd CK; Smits SM; Smidt MP; Klein R; Dyck RH; Simon HH
    J Neurochem; 2004 Dec; 91(6):1302-11. PubMed ID: 15584907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons.
    Abe Y; Namba H; Zheng Y; Nawa H
    Neuroscience; 2009 Jun; 161(1):95-110. PubMed ID: 19298847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of dopaminergic neurons in the mammalian brain.
    Prakash N; Wurst W
    Cell Mol Life Sci; 2006 Jan; 63(2):187-206. PubMed ID: 16389456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and function of the midbrain dopamine system: what we know and what we need to.
    Bissonette GB; Roesch MR
    Genes Brain Behav; 2016 Jan; 15(1):62-73. PubMed ID: 26548362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window.
    Nawa H; Sotoyama H; Iwakura Y; Takei N; Namba H
    Biomed Res Int; 2014; 2014():697935. PubMed ID: 24949465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vulnerability of dopamine circuit development to cytokines from the periphery: implication in schizophrenia].
    Sotoyama H; Nawa H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):209-15. PubMed ID: 22256609
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.